Committee Chair (2023–26)

Arnold H. Seto, MD, MPA, FSCAI
Board (2023–24)

Joaquin E. Cigarroa, MD, MSCAI
SHD (2020-26)

Andrew M. Goldsweig, MD, MSc, FSCAI
AMA HOD (2019-26)

J. Jeffrey Marshall, MD, MSCAI
CPT (2018-25)

Arthur C. Lee, MD, FSCAI
Finance (2021–24)

Arnold H. Seto, MD, MPA, FSCAI
Goals
- Evaluate proposed legislation to understand its impact on interventional cardiologists and our patients.
- Ongoing outreach to federal agencies (evaluate and develop comment letters in response to proposed FDA, CMS, NIH, AHRQ federal regulations, getting to know agencies/outreach to federal agencies, assess existing relationships with agencies).
- Support select new interventional cardiology technologies by advocating for coverage and reimbursement of those technologies, when appropriate to support patient-centered decision making.
- Engage in federal and state-level legislative and regulatory proposals to positively influence the outcome.
- Identifying members who have strong contacts with key members of Congress.
2022-25

Clifford J. Kavinsky, MD, PhD, MSCAI
2022-25
